Perficient Acquires BioPharm Systems
BioPharm Systems, a global IT consulting and managed services provider in the life sciences industry, has been acquired by Perficient.
BioPharm Systems, a global IT consulting and managed services provider in the life sciences industry, has been acquired by Perficient, a global IT consulting firm in many vertical markets. The acquisition of BioPharm Systems is Perficient's first in the life sciences space. According to a press release, the acquisition gives Perficient its vertical expertise in life sciences, specially in clinical trial management, clinical data management and safety and pharmacovigilance solutions; strengthens the company's Oracle-based partnerships and capabilities and adds life sciences clients including Bayer, CR Bard, Halozyme Therapeutics, Ikaria, Johnson & Johnson, Medtronic, Pfizer, St. Jude Medical, Stryker, and Sunovion. BioPharm Systems President and CEO Alex Sefanov joins the company in a key leadership role, as do 50 other professionals from the company.
Read the full release here.
Including Women of Childbearing Age in Clinical Research
March 26th 2024In recognition of International Women's Month, we're featuring this recent talk between Associate Editor Miranda Schmalfuhs and Marie Teil, Global Head of UCB’s Women of Childbearing Age Program. They speak about the specific challenges women with chronic illnesses face when accessing appropriate treatment and participating in clinical trials, UCB's Women of Childbearing Age Program and it’s most successful strategies, and much more.
Regulatory Compliance With eCOAs
April 26th 2024In the fourth and final part of this video interview with ACT editor Andy Studna, Melissa Mooney, director, eCOA sales engineering, IQVIA discusses how the regulatory stance on electronic clinical outcome assessments has changed over the years and what it could look like in the future.
Improving Engagement While Maintaining Data Integrity & Validity
March 19th 2024In recognition of Women's Health Month, we're featuring this recent talk between Associate Editor Miranda Schmalfuhs and uMotif's Chief Product Officer, Julia Lakeland, discuss new technologies improving patient engagement and reducing the emotional and logistical burdens of participation, ethical considerations that should be addressed when implementing those technologies, while ensuring patient privacy, and much more.
Using Patient Reported Outcomes in Dermatology Trials
April 25th 2024In part 3 of this video interview with ACT editor Andy Studna, Melissa Mooney, director, eCOA sales engineering, IQVIA sheds light on the unique challenges of dermatology trials and how clinical outcome assessments can be implemented in them.
